Continuous Glucose Monitoring Captures Glycemic Variability After Roux-en-Y Gastric Bypass in Patients with and Without Type 2 Diabetes Mellitus: A Prospective Cohort Study
Authors:
- Raquel Do A. P. QuevedoRQRaquel Do A. P. Quevedo
- Maria Edna de MeloMMMaria Edna de Melo
- Cintia CercatoCCCintia Cercato
- Ariana E. FernandesAFAriana E. Fernandes
- Anna Carolina B. DantasADAnna Carolina B. Dantas
- Marco Aurélio SantoMSMarco Aurélio Santo
- Denis PajeckiDPDenis Pajecki
- Marcio C. ManciniMMMarcio C. Mancini
- 13 July 2024
- journal article
- research article
- Published by Springer Nature in Obesity Surgery
- Vol. 34 (8) , 2789-2798
Abstract
Purpose To evaluate glycemic variability (GV) using continuous glucose monitoring (CGM) in individuals with and without type 2 diabetes mellitus (T2DM) undergoing Roux-en-Y gastric bypass (RYGB). Methods This prospective cohort study compared the CGM data of fourteen patients with T2DM (n = 7) and without T2DM (n = 7) undergoing RYGB. After 6 months, these patients were compared to a non-operative control group (n = 7) matched by BMI, sex, and age to the T2DM group. Results Fourteen patients underwent RYGB, with a mean BMI of 46.9 ± 5.3 kg/m2 and an average age of 47.9 ± 8.9 years; 85% were female. After 6 months post-surgery, the total weight loss (TWL) was 27.1 ± 6.3%, with no significant differences between the groups. Patients without diabetes had lower mean interstitial glucose levels (81 vs. 94 and 98 mg/dl, p < 0.01) and lower glucose management indicator (GMI) (5.2 vs. 5.6 and 5.65%, p = 0.01) compared to the control and T2DM groups, respectively. The coefficient of variation (CV) significantly increased only in patients with diabetes (17% vs. 26.7%, p < 0.01). Both groups with (0% vs. 2%, p = 0.03) and without (3% vs. 22%, p = 0.03) T2DM experienced an increased time below range with low glucose (54–69 mg/dL). However, patients without T2DM had significantly less time in rage (70–180 mg/dL) (97% vs. 78%, p = 0.04). Conclusion Significant differences in CGM metrics among RYGB patients suggest an increase in glycemic variability after surgery, with a longer duration of hypoglycemia, especially in patients without T2DM. Graphical AbstractKeywords
This publication has 24 references indexed in Scilit:
- Use of Continuous Glucose Monitoring in Patients Following Bariatric Surgery: A Scoping ReviewObesity Surgery, 2023
- Continuous glucose monitoring and metrics for clinical trials: an international consensus statementThe Lancet Diabetes & Endocrinology, 2022
- Continuous Glucose Monitoring in Bariatric Patients Undergoing Laparoscopic Sleeve Gastrectomy and Laparoscopic Roux-En-Y Gastric BypassObesity Surgery, 2019
- Diabetes remission after bariatric surgery is characterized by high glycemic variability and high oxidative stressNutrition, Metabolism and Cardiovascular Diseases, 2017
- Prevalence, severity, and predictors of symptoms of dumping and hypoglycemia after Roux-en-Y gastric bypassSurgery for Obesity and Related Diseases, 2016
- GLP-1 and GLP-2 Levels are Correlated with Satiety Regulation After Roux-en-Y Gastric Bypass: Results of an Exploratory Prospective StudyObesity Surgery, 2016
- Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trialDiabetologia, 2016
- Continuous Glucose Monitoring After Gastric Bypass to Evaluate the Glucose Variability After a Low-Carbohydrate Diet and to Determine HypoglycemiaObesity Surgery, 2016
- Recognition and management of hyperinsulinemic hypoglycemia after bariatric surgeryObesity Research & Clinical Practice, 2016
- Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular ComplicationsJAMA, 2014